Medication info
Cardiovalton Tablet 160/12.5 mg

Cardiovalton Tablet 160/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Dark red oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201207104 · Approved 2012.10.09 · Insurance code 645403780

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The blood pressure-lowering effect reaches its maximum after 2 ~ 4 weeks. ○ Patients with renal impairment No dosage adjustment is required in patients with mild ~ moderate renal impairment (creatinine clearance of 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not exceed 80 mg of valsartan per day.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Used in cases where blood pressure is not sufficiently controlled by monotherapy due to essential hypertension.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The blood pressure-lowering effect reaches its maximum after 2 ~ 4 weeks. ○ Patients with renal impairment No dosage adjustment is required in patients with mild ~ moderate renal impairment (creatinine clearance of 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not exceed 80 mg of valsartan per day.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, or with certain liver or kidney diseases should not take it. Patients with electrolyte imbalances, renal or liver dysfunction, elderly patients, and those with heart conditions should use this medication with caution. Dizziness or drowsiness may occur while taking this medication; caution is required when driving or operating machinery. This drug may affect potassium levels, so potassium supplements should not be taken without consulting a doctor, and regular blood tests are necessary. Additionally, as this medication may interact with other drugs, it is essential to inform healthcare providers about any medications being taken. If unusual skin lesions, rash, itching, or difficulty breathing occur while taking this medication, immediate medical attention should be sought. In case of overdose, symptoms such as hypotension, dizziness, and vomiting may occur, requiring prompt treatment. It is advisable not to use this medication in children, pregnant, or breastfeeding women, as its safety has not been established.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, dyspnea, erectile dysfunction, enteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myalgia, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, pharyngalgia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, vascular edema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, anaphylactic-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, systemic lupus erythematosus exacerbation, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, vascular edema, rash, vesicular dermatitis, renal failure, joint pain, weakness, low back pain, diarrhea, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, acute respiratory distress syndrome, pneumonia, pulmonary edema, hypokalemia, increased blood lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, hyperglycemia, diabetes, worsening diabetic metabolism, urticaria, skin rash, photosensitivity reactions, necrotizing vasculitis, lupus erythematosus, loss of appetite, nausea, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, headache, dizziness, sleep disorder, depression, paresthesia, visual impairment, thrombocytopenia, leukopenia, agranulocytosis, bone marrow dysfunction, hemolytic anemia, erectile dysfunction, hypersensitivity reaction, acute renal failure, renal impairment, aplastic anemia, erythema multiforme, fever, muscle cramps, weakness, acute closed-angle glaucoma, choroidal exudate, hypotension, tachycardia, nausea, drowsiness, hypovolemia, arrhythmia, muscle stiffness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it should be kept in a cool place below 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Dark red oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.